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Predictions for future growth of ESRD prevalence. The Euro- vides information on individual patients. The informa-
pean Union (EU) has 15 member countries and a total popula- tion used in this analysis has come from the center
tion of 373 million. In 1995 the incidence of new patients start- questionnaire. The information in this questionnaire in-ing renal replacement therapy (RRT) was 120 per million
cludes the number of new patients starting RRT, thepopulation (pmp). The overall incidence of death was 67 pmp
modality of first RRT, number of patients dying on RRTand the total number of patients alive on treatment was 644
pmp. During this year, the pool of patients expanded by 8.2%. during the year, total number of patients alive, number
These overall figures concealed large differences between of patients receiving a renal transplant and number of
countries. For example, the incidence of new patients varied patients alive with a functioning transplant.from 69 pmp to 163 pmp, the stock of patients on RRT varied
In 5 of the 15 countries comprising the EU, the re-from 444 pmp to 773 pmp and the expansion rate of the pool
sponse rate to the annual questionnaire was 100%. Forof RRT patients varied form 2.3% to 13%. On the basis of
these figures, it is likely that the stock of patients will continue six other countries the rate fell between 80% and 100%,
to increase steadily, but at a slowly diminishing rate, to reach while the response in the remaining four countries was
a figure of 1000 pmp by 2001 or 2002.
between 65% and 80%. The mean response for all 15
countries was 84%. In order to estimate the true numbers
of patients receiving treatment for countries with re-
The ERA-EDTA Registry was established in 1965.
sponse rates less than 100%, the numbers reported were
By 1999, it covered 43 countries with a total population
extrapolated to provide an estimate for a response rateof 716 million and was receiving information from more
of 100%.than 3500 centers either directly or through National
Registries; its database contained information on more
than 500,000 patients. Because it is a voluntary registry, RESULTS
returns of data are very variable and in general are much Table 1 summarizes the information obtained for the
better from those countries with National Registries than EU countries for 1995 [1]. The mean incidence of pa-
those without. Data returns also tend to be better from tients starting RRT was 120 per million population
Western European countries than from some of the (pmp), but the number for individual countries varied
other countries that contribute to the Registry. In order from 68 pmp in Finland to 163 pmp in Germany. The
to obtain accurate information, this analysis has been mean incidence of deaths among treated patients was 67
confined to the 15 countries of the European Union
pmp, but again, there was a wide range from 35 pmp in
(EU). By looking at the data from 1995, one can obtain
Ireland to 89 pmp in Germany. The mean point preva-
some idea of the trends in renal replacement therapy
lence of treated patients was 644 pmp with a range from(RRT) and thus predict future growth of the RRT popu-
444 pmp in Finland to 760 pmp in Germany. As onelation.
would expect, the rate of new patients starting treatment
exceeded the number of deaths in all countries, and the
METHODS expansion of the pool of patients on RRT varied from
2.3% in Greece to 13% in Luxembourg, with a meanThe ERA-EDTA Registry gathers information on an
figure of 8.2%.annual basis either directly from renal centers or through
Rates of renal transplantation varied widely withinNational Registries. Information is obtained through a
the EU, as shown in Table 2 [1]. In 1995, the lowest ratecenter questionnaire, which contains core epidemiologi-
was in Greece at 14 pmp, with the highest in Spain at 45cal data, and through a patient questionnaire, which pro-
pmp. Some countries have a long established transplant
program, while in others it has expanded more recently.
Key words: registry, chronic renal failure, renal replacement therapy. Thus, although there is a wide range in the number of
patients alive with a functioning transplant, these figures 2000 by the International Society of Nephrology
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Table 1. RRT in Europe, 1995
Patients Deaths Stock Expansion rate
Country Populationa starting RRTb on RRTb of patientsb of RRT pool (%)
Austria 8.1 115 73 583 7.3
Belgium 10.2 116 79 652 5.6
Denmark 5.2 98 62 496 7.1
Finland 5.1 68 48 444 4.6
France 58.1 112 58 580 9.3
Germany 81.7 163 89 760 9.8
Greece 10.5 75 62 586 2.3
Ireland 3.6 69 35 640 5.4
Italy 57.7 131 80 773 6.7
Luxembourg 0.4 155 75 618 13.0
Netherlands 15.5 82 53 511 5.6
Portugal 9.9 127 65 610 10.0
Spain 39.1 121 57 700 9.2
Sweden 8.9 99 68 604 5.1
United Kingdom 58.6 87 47 476 8.4
Total EU 372.6 120 67 644 8.2
a Millions
b Per million population
Table 2. Treatment of ESRF by renal transplantation in Europe, 1995
Expansion rate
Transplants Patients with of pool of patients with
Country Populationa in 1995b functioning transplantsb functioning transplant (%)
Austria 8.1 35 262 4.6
Belgium 10.2 28 278 7.6
Denmark 5.2 28 225 4.1
Finland 5.1 33 275 5.6
France 58.1 28 193 9.0
Germany 81.7 30 185 7.7
Greece 10.5 14 91 9.8
Ireland 3.6 32 503 3.0
Italy 57.7 24 155 9.7
Luxembourg 0.4 33 243 8.2
Netherlands 15.5 29 256 7.0
Portugal 9.9 38 57 50.7
Spain 39.1 45 269 10.8
Sweden 8.9 37 318 5.0
U.K. 58.6 25 247 4.6
Total E.U. 372.6 30 209 7.9
a Millions
b Per million population
do not always reflect the current transplant activity but much less than in the USA and Japan. This results
within the country. The range of patients alive with a in a much lower stock of patients in the EU countries
functioning transplant was wide, from 57 pmp in Portugal than in the USA and Japan. However, it is interesting
to 503 pmp in Ireland. This low figure in Portugal was to note that the death rate when expressed as a percent-
despite the fact that in 1995 the transplant rate in Portu- age of the total stock of RRT patients was no higher in
gal was the second highest among all EU countries. Japan than in the EU, although it was much higher in
These trends are also illustrated by the expansion rate the USA. Finally, the expansion of the pool of patients
in the pool of patients with functioning transplants. This was only slightly higher in the EU than in the USA and
rate was 51% in Portugal and only 3% in Ireland, despite Japan despite the much lower stock of patients in the EU.
the fact that the current transplant rate in Ireland is not
far short of that in Portugal.
DISCUSSIONTable 3 compares information from the ERA-EDTA
The information available in the ERA-EDTA Regis-Registry [1] with that of Registries in the United States,
try has been analyzed for 1995 in order to try and predictCanada, and Japan [2–4]. One can see that the incidence
of new patients in the EU is similar to that in Canada, future treatment trends and in particular the growth of
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Table 3. RRT data for world registries in 1995
Patients Stock Death rate Expansion rate
Country Population a starting RRT b of patientsb (% of RRT patient pool) of RRT pool (%)
USA 262.8 262 1013 18.9 7.0
Japan 125.6 210 1230 9.3 7.8
Canada 29.6 104 613 10.4 6.6
EU 372.6 120 644 10.4 8.2
a Millions
b Per million population
new patients receiving RRT. As the information is more While live donor transplantation is utilized to a much
greater extent in northern Europe than in southern Eu-complete for the countries of the EU than for the ERA-
rope, its potential is not nearly sufficient to make up theEDTA Registry as a whole, the analysis was confined
shortfall in cadaver organs.to these 15 countries. However, even within the EU,
Comparison of the data from the EU with that of otherepidemiological data are not complete, particularly for
world Registries shows a somewhat similar position inthe 6 countries that do not yet have fully functioning
Canada [3] and the EU, but there is a much lower inci-National Registries. In order to estimate the total num-
dence and prevalence of dialysis than in Japan [4] andber of patients as accurately as possible, the figures used
the USA [2]. The difference is particularly striking within this analysis were obtained by extrapolation of the
regard to Japan when one considers that its RRT pro-numbers reported for countries with a response rate of
gram relies almost exclusively on dialysis, with a veryless than 100%.
small contribution from transplantation.The wide variation within the EU in the number of
An examination of the current expansion rate of RRTpatients receiving treatment is due to a number of fac-
in the EU enables us to predict numbers over the nexttors. There are probably genuine differences in the inci-
few years with reasonable accuracy, as it is unlikely thatdence of chronic renal failure but accurate data on this
there will be any major change in the trends over theis not available. The variation in dialysis rates is due to
next few years. It is likely that the present annual expan-a considerable extent to the economic prosperity of the
sion rate of RRT patients in the EU of around 8% willindividual country but it probably also relates to the
fall slowly but remain in the range of 6% to 8% overmethod of organization of health care and the system of
the next few years. If one assumes this, the stock ofreimbursement for dialysis.
patients will have risen from the figure of 644 pmp in
The wide variation in rates of transplantation between 1995 to 1000 pmp by 2001 or 2002. Within the EU, how-
countries has somewhat different reasons. The countries ever, the wide variation between countries in total pa-
of northern Europe have relied on transplantation to a tient numbers and distribution between the various
greater extent in the past than those in southern Europe. forms of RRT is likely to persist.
However, this position is now changing, mainly as a result
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